EMPOWER PHARMA
Live / Registered — Registered (as of 03 Mar 2026)
What this means for you
Registered since 03 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98294312
- Registration number
- 8156028
- Mark type
- Design + words
- Filed
- 01 Dec 2023
- Published for opposition
- 03 Sept 2024
- Registered
- 03 Mar 2026
- Attorney of record
- JOHN A YATES
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for weight management, hormone replacement therapy, intravenous therapy, intravenous nutrition, injectable therapy, dietary nutrition, mental health, skin care, sexual dysfunction, fertility, men's health, and women's health; pharmaceutical preparations for the prevention, reduction, and treatment of cardiovascular, lymphatic, respiratory, pulmonary, neurological, renal, gastrointestinal, musculoskeletal, dermatological, allergic, inflammatory, autoimmune, gynecological, genetic, longevity, metabolic, and pain conditions; disinfecting wipes; and sanitizing wipes
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals
Owner
- Empower Clinic Services, LLC, Houston, TX, US
- Empower Clinic Services, LLC, Houston, TX, US
- Empower Clinic Services, LLC, Houston, TX, US
Prosecution history
- 03 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 09 Feb 2026 — TTAB RELEASE CASE TO TRADEMARKS
- 09 Feb 2026 — OPPOSITION TERMINATED NO. 999999
- 09 Feb 2026 — OPPOSITION DISMISSED NO. 999999
- 30 Jan 2026 — OPPOSITION DISMISSED NO. 999999
- 01 Jan 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 03 Oct 2024 — OPPOSITION INSTITUTED NO. 999999
- 02 Oct 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2024 — PUBLISHED FOR OPPOSITION
- 14 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE